You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HIV Treatment Vaccine

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in United States (VSV-Indiana HIV gag vaccine, Placebo injection (normal saline))

Completed
  • HIV Infections
  • VSV-Indiana HIV gag vaccine
  • Placebo injection (normal saline)
  • San Francisco, California
  • +3 more
Oct 13, 2021

HIV Trial in United States (MPER-656 Liposome Vaccine, Placebo for MPER-656 Liposome Vaccine)

Completed
Has Results
  • HIV Infections
  • MPER-656 Liposome Vaccine
  • Placebo for MPER-656 Liposome Vaccine
  • Birmingham, Alabama
  • +5 more
Jun 15, 2022

RZV Vaccine (Shingrix ®) Trial in France, Switzerland (Recombinant Zoster Vaccine)

Not yet recruiting
  • RZV Vaccine (Shingrix ®)
  • Recombinant Zoster Vaccine
  • Bordeaux, France
  • +7 more
Oct 27, 2022

Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in

Active, not recruiting
  • SARS-CoV-2 RNA Vaccines
  • HIV Infection
  • SARS-CoV-2 Vaccine
  • Sevilla, Spain
    Virgen del Rocio University Hospital
Dec 1, 2022

Healthy Adults Trial in Créteil (Solo 0.3 group, Solo 1 group, Solo 3 group)

Recruiting
  • Healthy Adults
  • Solo 0.3 group
  • +5 more
  • Créteil, France
  • +2 more
Sep 9, 2022

HIV Trial in South Africa (ALVAC-HIV (vCP2438), Bivalent Subtype C gp120/MF59, Placebo)

Completed
  • HIV Infections
  • ALVAC-HIV (vCP2438)
  • +2 more
  • Mthatha, Eastern Cape, South Africa
  • +13 more
May 17, 2022

HIV Trial in Iowa City, New York (Tetanus Toxoid Vaccine, Hepatitis A Vaccine (Inactivated), HIV-1 Immunogen)

Completed
  • HIV Infections
  • Tetanus Toxoid Vaccine
  • +3 more
  • Iowa City, Iowa
  • +1 more
Oct 27, 2021

HIV, HIV Seronegativity Trial in United States (ALVAC-HIV MN120TMG (vCP205))

Completed
  • HIV Infections
  • HIV Seronegativity
  • ALVAC-HIV MN120TMG (vCP205)
  • Birmingham, Alabama
  • +5 more
Oct 28, 2021

HIV Trial in Boston, Seattle (HIV-1 DNA plasmid vaccine, HIV-1 recombinant Ad5 vaccine)

Completed
  • HIV Infections
  • HIV-1 DNA plasmid vaccine
  • HIV-1 recombinant Ad5 vaccine
  • Boston, Massachusetts
  • +1 more
Oct 13, 2021

HIV Trial in Chicago, Durham, Galveston (Interleukin-12, HIV-1 C4-V3 Polyvalent Peptide Vaccine)

Completed
  • HIV Infections
  • Chicago, Illinois
  • +2 more
Oct 28, 2021

HPV, Human Papilloma Virus, Human Immunodeficiency Virus Trial in Vancouver (Nonavalent HPV vaccine)

Not yet recruiting
  • HPV
  • +2 more
  • Nonavalent HPV vaccine
  • Vancouver, British Columbia, Canada
    University of British Columbia
Aug 8, 2022

HIV Trial in United States (MRKAd5 HIV-1 gag/pol/nef)

Completed
  • HIV Infections
  • MRKAd5 HIV-1 gag/pol/nef
  • Birmingham, Alabama
  • +3 more
Oct 13, 2021

HIV Trial in Switzerland, United States (DNA-HIV-PT123 vaccine, NYVAC-HIV-PT1 vaccine, NYVAC-HIV-PT4 vaccine)

Completed
  • HIV Infections
  • DNA-HIV-PT123 vaccine
  • +5 more
  • Birmingham, Alabama
  • +7 more
Oct 13, 2021

HIV Trial in Worldwide (PENNVAX-G DNA Vaccine, MVA-CMDR Vaccine, Placebo PENNVAX-G Vaccine)

Completed
  • HIV Infections
  • PENNVAX-G DNA Vaccine
  • +3 more
  • Rockville, Maryland
  • +3 more
Oct 28, 2021

HIV Infection Trial in Brazil, Peru, United States (Analytical Treatment Interruption)

Recruiting
  • HIV Infection
  • Analytical Treatment Interruption
  • Los Angeles, California
  • +11 more
Jan 13, 2023

HPV - Anogenital Human Papilloma Virus Infection, HIV Trial in Brussels (Vaccine)

Active, not recruiting
  • HPV - Anogenital Human Papilloma Virus Infection
  • HIV Infections
  • Vaccine
  • Brussels, Belgium
    Service de Maladies Infectieuses, CHU Saint-Pierre
Jul 19, 2022

HIV Trial in United States (HIV-MAG vaccine, IL-12 pDNA adjuvant, VSV HIV gag vaccine)

Completed
  • HIV Infections
  • HIV-MAG vaccine
  • +4 more
  • New York, New York
  • +4 more
Oct 13, 2021

HIV Trial in United States (GEO-D03 DNA vaccine, MVA/HIV62B (MVA62B) vaccine, Placebo for GEO-D03 DNA)

Completed
  • HIV Infections
  • GEO-D03 DNA vaccine
  • +3 more
  • Birmingham, Alabama
  • +3 more
Oct 13, 2021

HPV Infection, Hiv, HPV Vaccine Trial in Swaziland (Gardasil ® 9)

Recruiting
  • HPV Infection
  • +2 more
  • Gardasil ® 9
  • Bulembu, Swaziland
  • +7 more
May 16, 2022

HIV Trial in United States (Clade B gag DNA/PLG and env DNA/PLG Microparticles, Clade B Recombinant, Oligomeric gp140/MF59

Completed
  • HIV Infections
  • Clade B gag DNA/PLG and env DNA/PLG Microparticles
  • Clade B Recombinant, Oligomeric gp140/MF59 Adjuvant
  • Saint Louis, Missouri
  • +3 more
Oct 13, 2021

SARS-CoV, SARS-CoV-2 Trial in Durban, Soweto (VXCO-100, COVID-19 mRNA vaccine and VXCO-100, COVID-19 mRNA vaccine)

Not yet recruiting
  • SARS-CoV
  • SARS-CoV-2
  • VXCO-100
  • +2 more
  • Durban, South Africa
  • +1 more
Jul 5, 2023

HIV Trial in Columbus, Pittsburgh (Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant, Placebo control for Trimer 4571 vaccine

Recruiting
  • HIV Infections
  • Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant
  • +3 more
  • Columbus, Ohio
  • +1 more
Apr 10, 2022

HIV Trial in Entebbe, Kampala (ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein (vCP65))

Completed
  • HIV Infections
  • ALVAC-HIV MN120TMG (vCP205)
  • ALVAC-RG Rabies Glycoprotein (vCP65)
  • Entebbe, Uganda
  • +1 more
Oct 28, 2021

HIV Trial in Mozambique, South Africa, Zimbabwe (ALVAC-HIV (vCP2438), Bivalent Subtype C gp120/MF59, Bivalent Subtype C gp120

Completed
Has Results
  • HIV Infections
  • ALVAC-HIV (vCP2438)
  • +3 more
  • Maputo, Mozambique
  • +5 more
Nov 18, 2021

HIV-1-infection Trial in Los Angeles, San Francisco (PENNVAX-GP, INO-6145, INO-9012)

Completed
  • HIV-1-infection
  • PENNVAX-GP
  • +3 more
  • Los Angeles, California
  • +1 more
Apr 4, 2022